- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q1 2026 · Mar 31, 2026 | $2.64M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.79M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $13.83M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $8.15M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $204.5M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $197.5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $59.45M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $57.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $438.94M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $425.51M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $124.75M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $127.45M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $416.21M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $416.53M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $397.15M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $384.76M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $951.92M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $935.2M |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $584.42M |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $36.73M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $29.51M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $8.51M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $7.22M |
| Net Income | Q1 2026 · Mar 31, 2026 | $11.38M |
| Net Income | Q1 2026 · Mar 31, 2025 | $17.87M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $23.67M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $25.02M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $69.6M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $58.82M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $108.89M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $93.42M |
| Revenue | Q1 2026 · Mar 31, 2026 | $178.49M |
| Revenue | Q1 2026 · Mar 31, 2025 | $152.24M |